Efficacy and safety of switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low-level viremia: a real-world 48-week extension study
Zhongbin Li(Chinese PLA General Hospital), Zhaoxia Yu(University of California, Irvine), Bing Qiao(Qingdao Eighth People's Hospital), Dong Ji(Humanity & Health), Qingjuan He(Qingdao Eighth People's Hospital), Yunfei Jia(Xi'an University of Science and Technology), Li Cui(Tianjin University), Xu-Yang Li(Kunming Institute of Botany), Dandan Chen(Zhejiang Chinese Medical University), Ping Li(Shandong Normal University), Chunyan Wang(Washington University in St. Louis), Jie Zhou(Tsinghua University), Chang Guo(Chinese PLA General Hospital), Wenchang Wang(Changzhou University), Yiming Fu(Chinese PLA General Hospital), Ying Dai(Qiqihar Medical University), Yun Zhao(Chinese PLA General Hospital), Yifan Guo(Capital University), Jianjun Wang, Weihua Zhang
Cited by 2
Related Papers
Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla
|Proceedings of the National Academy of Sciences|2009|758
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Meta-analysis identifies multiple loci associated with kidney function–related traits in east Asian populations
|Nature Genetics|2012|333
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy
|Autophagy|2010|249